An early phase 2 study with XELODA™ (capecitabine) in patients with metastatic breast cancer

被引：0
|
作者：
Saeki, T
Takashima, S
Terashima, M
Tabei, T
Enomoto, K
Tominaga, T
Kimura, T
Miura, S
Koyama, H
Konishi, Y
Oka, T
Naito, Y
Sonoo, H
Toge, T
Dohi, K
Nomizu, T
Taguchi, T
机构：
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
594
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [21] Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer
    Pusztai, L
    Zhen, JH
    Arun, B
    Rivera, E
    Whitehead, C
    Thompson, WJ
    Nealy, KM
    Gibbs, A
    Symmans, WF
    Esteva, FJ
    Booser, D
    Murray, JL
    Valero, V
    Smith, TL
    Hortobagyi, GN
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (18) : 3454 - 3461
  • [22] Phase II study of carboplatin, vinorelbine and capecitabine in patients with metastatic breast cancer.
    Rabinowitz, MJ
    Mangalik, A
    Lee, FC
    Cynthia, C
    Claire, V
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S203 - S203
  • [23] Xeloda® in the treatment of metastatic breast cancer
    Blum, JL
    ONCOLOGY, 1999, 57 : 16 - 20
  • [24] Quality of Life under Capecitabine (Xeloda®) in Patients with Metastatic Breast Cancer: Data from a German Non-Interventional Surveillance Study
    Mueller, Volkmar
    Fuxius, Stefan
    Steffens, Claus-Christoph
    Lerchenmueller, Christian
    Luhn, Birgit
    Vehling-Kaiser, Ursula
    Hurst, Ursula
    Hahn, Lars-Joergen
    Soeling, Ulrike
    Wohlfarth, Tim
    Zaiss, Matthias
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (12) : 748 - 755
  • [25] Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy A retrospective study
    Li, Yi-Hui
    Zhou, Yang
    Wang, Yu-Wei
    Tong, Ling
    Jiang, Run-Xue
    Xiao, Lei
    Zhang, Guang-Ju
    Xing, Shu-Shan
    Qian, Fang
    Feng, Jing-Qi
    Zhao, Ya-Ling
    Wang, Jian-Gong
    Wang, Xiao-Hong
    MEDICINE, 2018, 97 (36)
  • [26] Xeloda (capecitabine) potentialities in the treatment of cancer patients (review)
    Orel, NF
    TERAPEVTICHESKII ARKHIV, 2003, 75 (10) : 65 - 70
  • [27] Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer
    Northfelt, Donald W.
    Allred, Jacob B.
    Liu, Heshan
    Hobday, Timothy J.
    Rodacker, Mark W.
    Lyss, Alan P.
    Fitch, Tom R.
    Perez, Edith A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (02): : 167 - 171
  • [28] Phase I study of capecitabine in combination with paclitaxel in patients with previously treated metastatic breast cancer
    Villalona-Calero, M
    Blum, J
    Diab, S
    Elledge, R
    Khoury, P
    Kraynak, M
    Moczygemba, J
    Kromelis, P
    Impellizeri, K
    Griffin, T
    Von Hoff, D
    Rowinsky, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [29] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study
    Tanaka, Maki
    Takamatsu, Yasushi
    Anan, Keisei
    Ohno, Shinji
    Nishimura, Reiki
    Yamamoto, Yutaka
    Masuda, Norikazu
    Mitsuyama, Shoshu
    Tamura, Kazuo
    ANTI-CANCER DRUGS, 2010, 21 (04) : 453 - 458
  • [30] A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Estevez, Laura G.
    Batista, Norberto
    Sanchez-Rovira, Pedro
    Velasco, Amalia
    Provencio, Mariano
    Leon, Ana
    Domine, Manuel
    Cruz, Josefina
    Rodriguez, Milva
    CLINICAL BREAST CANCER, 2008, 8 (02) : 149 - 154
12345